Johnson & Johnson will supply COVAX 200 million of its single-dose COVID-19 vaccines by the end of the year, according to a statement on Friday by Gavi, the Vaccine Alliance, announcing the advance purchase agreement. The vaccine will be available to both COVAX members who buy their own vaccines and the COVAX AMC members.  “Today’s […] Continue reading ->
Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which  further exacerbates inequality and lack of access to vaccines for vulnerable groups.  That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading ->
Researchers have quickly developed an outstanding arsenal of vaccines, treatments and diagnostics to counter COVID-19. But closer global coordination of diverse clinical trials testing the same or similar treatments, extending even to a global platform to pool anonymized patient data, could strengthen and accelerate research findings – especially as emerging variants threaten to unwind gains. […] Continue reading ->
Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading ->
Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over.  Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading ->
The World Health Organization (WHO) has decided to classify the B1.617 variant first identified in India as a “variant of concern”, according to Maria Van Kerkhove, WHO lead on COVID-19. “There is some available information to suggest increased transmissibility of B1.617,” Van Kerkhove explained to the WHO’s biweekly media briefing on Monday. In addition, a […] Continue reading ->